Acute autoimmune myocarditis and hepatitis due to ipilimumab monotherapy for malignant melanoma

Life-threatening Autoimmune Cardiomyopathy Reproducibly Induced in a Patient by Checkpoint Inhibitor Therapy

(2018) Azadeh Tajmir-Riahi et al.   JOURNAL OF IMMUNOTHERAPY

Immune-related fulminant myocarditis in a patient receiving ipilimumab therapy for relapsed chronic myelomonocytic leukaemia

(2017) David D. Berg et al.   EUROPEAN JOURNAL OF HEART FAILURE

Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors

(2016) Daphne Day et al.   BIODRUGS

Fulminant Myocarditis with Combination Immune Checkpoint Blockade

(2016) Douglas B. Johnson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Late-onset pericardial tamponade, bilateral pleural effusions and recurrent immune monoarthritis induced by ipilimumab use for metastatic melanoma

(2016) Constantin A Dasanu et al.   JOURNAL OF ONCOLOGY PHARMACY PRACTICE

Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy

(2016) Lucie Heinzerling et al.   Journal for ImmunoTherapy of Cancer

The heart of the matter: Protection of the myocardium from T cells

(2013) Andrew H. Lichtman   JOURNAL OF AUTOIMMUNITY

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE